Cargando…

635. Is Azole Prophylaxis in Liver Transplant Recipients Effective in Preventing Invasive Candidiasis in the Era of Emerging Resistance?

BACKGROUND: Antifungal prophylaxis (px) in liver transplant (LT) recipients reduces invasive candidiasis (IC) and its associated mortality. Studies from our institution (UPMC) and others have shown that targeted px was as effective as universal px. Antifungal resistance has emerged among Candida spp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurram, Pooja R, Silveira, Fernanda P, Kwak, Eun Jeong, Clancy, Cornelius, Nguyen, Minh-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751765/ http://dx.doi.org/10.1093/ofid/ofac492.687

Ejemplares similares

357. Aspergillus Isolates Remain Largely Susceptible to Azoles and Other Antifungals at a Large Transplant Program Using Azole Prophylaxis
por: Driscoll, Eileen, et al.
Publicado: (2018)

938. Azole Resistant Aspergillus Species in Lung Transplant Recipients: A 10 Year Experience
por: Marschalk, Nicholas A, et al.
Publicado: (2021)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

1571. Cost-Effectiveness Analysis of Duration of Valganciclovir Prophylaxis Among CMV Serology Mismatched (Donor+/Recipient−) Lung Transplant Recipients
por: Tomko, Heather, et al.
Publicado: (2018)

Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences
por: Clancy, Cornelius J., et al.
Publicado: (2018)

1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
por: Roumpz, Caroline G, et al.
Publicado: (2021)

Invasive candidiasis serological diagnosis in solid organ transplant recipients
por: Piskorska, Katarzyna, et al.
Publicado: (2014)

1737. Impact of Therapeutic Drug Monitoring (TDM) of Azole Prophylaxis in Lung Transplant Recipients on the Development of Positive Fungal Events
por: Shah, Anooj, et al.
Publicado: (2019)

Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
por: Shields, Ryan K., et al.
Publicado: (2012)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

1101. Pulmonary Aspergillosis Complicating Non-Influenza Respiratory Virus Infections Among Solid Organ Transplant Recipients
por: Apostolopoulou, Anna, et al.
Publicado: (2020)

738. Potent In Vitro activity of Rezafungin (RZF) Against Aspergillus Clinical Isolates Recovered From Lung Transplant Patients Who Have Received ≥3 Months of Triazole Prophylaxis
por: Driscoll, Eileen, et al.
Publicado: (2019)

Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients
por: Peleg, Anton Y., et al.
Publicado: (2009)

Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant Recipients
por: Apostolopoulou, Anna, et al.
Publicado: (2021)

Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies
por: Clancy, Cornelius J., et al.
Publicado: (2016)

Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients
por: Klatt, Megan E., et al.
Publicado: (2021)

2887. Identifying Candida albicans Transcription Factors (TFs) That Regulate Pathogenesis of Intra-abdominal Candidiasis (IAC) by Screening a Deletion Mutant Library
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Management of early graft candidiasis in a kidney transplant recipient
por: Tan, Jaimee, et al.
Publicado: (2022)

1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin Resistance
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran
por: Katiraee, F, et al.
Publicado: (2015)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
por: Lotfali, Ensieh, et al.
Publicado: (2022)

2667. Does Ceftazidime–Avibactam (CAZ-AVI) Improve Short- and Long-Term Outcomes Among Solid-Organ Transplant (SOT) Recipients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections?
por: Sun, Jonathan, et al.
Publicado: (2019)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
por: Zhang, Ming-rui, et al.
Publicado: (2020)

Notable Increasing Trend in Azole Non-susceptible Candida tropicalis Causing Invasive Candidiasis in China (August 2009 to July 2014): Molecular Epidemiology and Clinical Azole Consumption
por: Fan, Xin, et al.
Publicado: (2017)

Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
por: Kim, Chun Soo
Publicado: (2020)

Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
por: Lamoth, Frederic, et al.
Publicado: (2020)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

Infections in Lung Transplant Recipients during and after Prophylaxis
por: Bae, Moonsuk, et al.
Publicado: (2020)

Exploring the Genome of a Butyric Acid Producer, Clostridium butyricum INCQS635
por: Bruce, Thiago, et al.
Publicado: (2014)

1136. Universal Prophylaxis for Prevention of Invasive Aspergillus in Lung Transplant Recipients
por: Guenette, Alexis, et al.
Publicado: (2018)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
por: Vuichard, Danielle, et al.
Publicado: (2014)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
por: Selvey, Linda A., et al.
Publicado: (2017)

ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis
por: You, Liangshun, et al.
Publicado: (2017)

Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability
por: Stelzer, Daniela, et al.
Publicado: (2017)

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
por: Arastehfar, Amir, et al.
Publicado: (2021)

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016)

CIN III lesions and regression: retrospective analysis of 635 cases
por: Motamedi, Melodi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1oqt9fk95ucmkj9q092c6dvakd